Thyrocare Technologies Ltd operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Thyrocare Technologies Ltd with three other
pharmaceutical manufacturers in Asia:
Interactive Entertainment China Cultural Technology Investments Ltd
of Hong Kong
sales of 404.74 million Hong Kong Dollars [US$51.61 million]
Medical & Biological Laboratories Company Limited
(7.35 billion Japanese Yen [US$67.61 million]
of which 99%
was Reagent business), and
Biotoxtech Company Limited
based in South Korea
(25.56 billion Korean Won [US$23.65 million]
During the year ended March of 2017, sales at
Thyrocare Technologies Ltd were 3.07 billion Indian Rupees (US$46.11 million).
increase of 27.3%
versus 2016, when the company's sales were 2.41 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Thyrocare Technologies Ltd
(and since 2012, sales have increased a total of 181%).
Sales of Others saw an increase
37.6% in 2017, from
111.25 million Indian Rupees to 153.10 million Indian Rupees.